Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...
Medpage Today on MSN6d
Faricimab Again Linked to Rare but Severe Eye Adverse EffectsAt a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback